Progyny, Inc.
Health
Performance
8.0
Risk
Sell
Buy
Curious about the Scores? Learn more.

Progyny, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

27.01.2026
Momentum tanked. Clearly underperforming.
14.01.2026
On shaky ground. Struggling to find a clear direction.
17.12.2025
Trouble brewing. Volatility and pressure rising.
20.08.2025
Health’s picking up. Numbers look cleaner, cash flow tighter.

Progyny, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Progyny, Inc. do? Business model and key facts

Get the full picture of Progyny, Inc.: what it builds, where it operates, and how it makes money.

Progyny, Inc. Profile

Sector: Healthcare

Industry: Medical - Healthcare Information Services

Employees (FY): 675

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

shop
Company facts
Peter Anevski
CEO
675
Employees worldwide
shop
Performance
5.66%
Last 12 months
-45.26%
Last 5 years
shop
Growth
$1,17B
Revenue year
$54,34M
Net income
shop
Valuation
$2,09B
Market Cap
29.04
Price/Earnings Ratio

Stocks related to Progyny, Inc.

Selected based on industry alignment and relative market positioning.

OMCL
Omnicell, Inc.
49.96
-0.72%
7.5
Sell
Buy
Omnicell, Inc.
PINC
Premier, Inc.
28.26
+0.32%
5.6
Sell
Buy
Premier, Inc.
WGS
GeneDx Holdings Corp.
96.01
-8.46%
10.0
Sell
Buy
GeneDx Holdings Corp.
CERT
Certara, Inc.
9.68
-4.25%
9.5
Sell
Buy
Certara, Inc.
SDGR
Schrödinger, Inc.
14.88
-4.19%
9.1
Sell
Buy
Schrödinger, Inc.

Progyny, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.